Adjunct treatments | |
---|---|
DIC treatments | 1498 (47%) |
Antithrombin | 990 (31%) |
Thrombomodulin | 856 (27%) |
Co-administration of antithrombin and thrombomodulin | 496 (16%) |
Protease inhibitors | 392 (12%) |
Heparinoids | 167 (5%) |
Immunoglobulin | 976 (31%) |
Low-dose steroids | 777 (24%) |
Renal replacement therapy | 890 (28%) |
Non-renal indication renal replacement therapy | 266 (8%) |
Polymyxin B-direct hemoperfusion | 692 (22%) |